Which of the following is the therapeutic classification of Mupirocin?

Mupirocin is classified as a topical antibacterial agent. This designation is due to its specific use in treating skin infections caused by certain bacteria. Mupirocin exerts its antibacterial effects by inhibiting protein synthesis in bacterial cells, which makes it effective against a variety of gram-positive bacteria, including Staphylococcus aureus, including MRSA (methicillin-resistant Staphylococcus aureus).

Being a topical agent, mupirocin is applied directly to the skin, targeting localized infections such as impetigo and infected wounds while minimizing systemic absorption and potential side effects. This route of administration is crucial for its effectiveness in treating superficial skin infections rather than systemic infections, which would require a different classification of antibacterial agents.

In essence, the therapeutic classification of mupirocin as a topical antibacterial accurately reflects its mechanism of action, its route of administration, and its primary indications in dermatological therapy.